Sanofi (EPA:SAN)
90.71
+0.32 (0.35%)
Apr 17, 2025, 5:39 PM CET
Sanofi Employees
Sanofi had 82,878 employees as of December 31, 2024. The number of employees decreased by 3,210 or -3.73% compared to the previous year.
Employees
82,878
Change (1Y)
-3,210
Growth (1Y)
-3.73%
Revenue / Employee
€534,352
Profits / Employee
€67,087
Market Cap
111.03B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 82,878 | -3,210 | -3.73% |
Dec 31, 2023 | 86,088 | -5,485 | -5.99% |
Dec 31, 2022 | 91,573 | -3,869 | -4.05% |
Dec 31, 2021 | 95,442 | -3,970 | -3.99% |
Dec 31, 2020 | 99,412 | -997 | -0.99% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
EssilorLuxottica Société anonyme | 153,498 |
Sartorius Stedim Biotech | 9,901 |
bioMérieux | 14,754 |
Eurofins Scientific SE | 62,696 |
Ipsen | 5,358 |
Virbac | 5,620 |
emeis Société anonyme | 77,954 |
Clariane SE | 61,798 |
Sanofi News
- 9 hours ago - Sanofi-Regeneron's Dupixent gets FDA's nod for skin condition - Reuters
- 9 hours ago - Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria - GlobeNewsWire
- 1 day ago - Earendil Labs and Sanofi partner for two bispecific antibodies - Seeking Alpha
- 3 days ago - Sanofi Asthma Drug Misses Primary Goal, Plans For Pivotal Study - Benzinga
- 3 days ago - Sanofi flunks mid-stage trial for asthma drug - Seeking Alpha
- 3 days ago - Press Release: Sanofi's respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD - Benzinga
- 3 days ago - Press Release: Sanofi's respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD - GlobeNewsWire
- 8 days ago - How Do Investors Really Feel About Sanofi? - Benzinga